CAS 1469337-91-4

K-Ras(G12C)inhibitor 9

Description:

K-Ras(G12C) inhibitor 9, identified by its CAS number 1469337-91-4, is a small molecule designed to selectively inhibit the K-Ras protein, particularly the G12C mutant form, which is implicated in various cancers. This compound exhibits characteristics typical of targeted cancer therapies, including high specificity for the mutant K-Ras protein, which allows for reduced off-target effects compared to traditional chemotherapeutics. The inhibitor functions by covalently binding to the cysteine residue at position 12 of the K-Ras protein, thereby blocking its activity and disrupting downstream signaling pathways that promote tumor growth and survival. In terms of its chemical structure, it likely contains functional groups that facilitate this interaction, contributing to its potency and efficacy. Additionally, K-Ras(G12C) inhibitor 9 is part of a broader class of compounds being explored in clinical settings, highlighting its potential role in precision medicine for treating K-Ras-driven malignancies. Its development reflects ongoing efforts to target specific mutations in cancer therapy, aiming to improve patient outcomes.

Synonyms:

• K-Ras(G12C) inhibitor 9

K-Ras(G12C) inhibitor 9

CAS: 1469337-91-4

K-Ras(G12C) inhibitor 9

Purity: ≥95%

Molecular weight: 513.78g/mol

Ref: 54-BUP07532

K-Ras(G12C) inhibitor 9

CAS: 1469337-91-4

K-Ras(G12C) inhibitor 9 is an allosteric inhibitor of oncogenic K-Ras(G12C).

Formula: C₁₆H₂₁ClIN₃O₄S

Purity: 97.33% - 97.45%

Color and Shape: Solid

Molecular weight: 513.78

Ref: TM-T6556

K-Ras(G12C) inhibitor 9

CAS: 1469337-91-4

K-Ras(G12C) inhibitor 9 is a diagnostic agent that has been shown to inhibit the expression of K-Ras(G12C) in human pancreatic cancer cells. It also has synergistic effects with erbb2 and medicines. K-Ras(G12C) inhibitor 9 can be used for the diagnosis of pancreatic cancer and other cancers that express Ras proteins, such as lung, breast, colon, prostate, and ovarian cancers. This reagent can be used to identify cancer cells by immunocytochemistry or immunohistochemistry.

Formula: C₁₆H₂₁ClIN₃O₄S

Purity: Min. 95%

Molecular weight: 513.78 g/mol

Ref: 3D-UIC33791